Appleby Advises Amanat Acquisition Corp. on USD377M Business Combination with Corxel Pharmaceuticals
Appleby has advised Amanat Acquisition Corp. on its proposed business combination with Corxel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company.
Supported by an approximately US$300 million concurrent PIPE financing, the proposed transaction is expected to generate approximately US$377 million in gross proceeds. The transaction is expected to complete in the first half of 2027, following which the combined company will be listed on the Nasdaq Capital Market.
Appleby’s team was led by Cayman Islands Partner Alexandra Low, supported by Hong Kong Counsel Alejandra Gonzalez Saucedo and Cayman Islands Articled Clerk Emily McIntyre, together with other members of the Corporate team.
The transaction further demonstrates Appleby’s strength in advising on significant cross-border transactions across the global capital markets.
